We demonstrated that, in contrast to classical opioid receptors, ACKR3 would not induce classical G protein signaling and isn't modulated because of the classical prescription or analgesic opioids, for example morphine, fentanyl, or buprenorphine, or by nonselective opioid antagonists like naloxone. Instead, we founded that LIH383, an ACKR3-selective subnanomolar https://robertt616uya7.wikicorrespondent.com/user